Stem Cell Research (Dec 2023)

Generation of a gene-corrected isogenic iPSC cell line from an X-linked retinoschisis patient with a hemizygous mutation c.304C > T (p.R102W) in RS1 gene

  • Shengru Mao,
  • Xihao Sun,
  • Chunwen Duan,
  • Bing Jiang,
  • Hongjie Ma,
  • Shangli Ji,
  • Yuqin Liang,
  • Ruting Zhang,
  • Jiansu Chen,
  • Shibo Tang

Journal volume & issue
Vol. 73
p. 103263

Abstract

Read online

X-linked retinoschisis (XLRS) is one of the most common retinal genetic diseases with progressive visual impairment in childhood affecting males. It is manifested with macular and/or peripheral schisis in neural retinas with no effective treatment. Previously, we successfully generated a human-induced pluripotent stem cell (iPSC) line from an XLRS patient carrying the hemizygous RS1 c. 304C > T (p.R102W) mutation. Here, we corrected the c.304C > T mutation in the RS1 gene using CRISPR/Cas9 technology to generate an isogenic control. This cell line is valuable for the study of XLRS.